Evidence map›Paper›PMID 35252679›Full record

ArticleACS omega2022

Structural Modifications and Biological Evaluations of Rift Valley Fever Virus Inhibitors Identified from Chemical Library Screening.

Koushikul Islam, Marcus Carlsson, Per-Anders Enquist, Weixing Qian, Marko Marttila, Mårten Strand, Clas Ahlm, Magnus Evander

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Koushikul IslamDepartment of Clinical Microbiology, Umeå University, Umeå 901 85, Sweden.
Marcus CarlssonDepartment of Chemistry, Umeå University, Umeå 901 87, Sweden.
Per-Anders EnquistDepartment of Chemistry, Umeå University, Umeå 901 87, Sweden.
Weixing QianDepartment of Chemistry, Umeå University, Umeå 901 87, Sweden.
Marko MarttilaDepartment of Clinical Microbiology, Umeå University, Umeå 901 85, Sweden.
Mårten StrandDepartment of Clinical Microbiology, Umeå University, Umeå 901 85, Sweden.
Clas AhlmDepartment of Clinical Microbiology, Umeå University, Umeå 901 85, Sweden.
Magnus EvanderDepartment of Clinical Microbiology, Umeå University, Umeå 901 85, Sweden.ORCID https://orcid.org/0000-0001-6034-4807
Umeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Rift Valley fever virus (RVFV) is an emerging high-priority pathogen endemic in Africa with pandemic potential. There is no specific treatment or approved antiviral drugs for the RVFV. We previously developed a cell-based high-throughput assay to screen small molecules targeting the RVFV and identified a potential effective antiviral compound (1-

Identifiers

PMID35252679
PMCPMC8892858
OpenAlexW2978340034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.